Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
In Situ Tumor Cell Membrane Editing Enhances PD-L1 Blockade
2026-07-23
This study introduces a self-assembling peptide nanoparticle, TPM1, that targets and aggregates PD-L1 on tumor cell membranes, enhancing immune checkpoint blockade efficacy. By leveraging in situ nanofibril transformation, the approach addresses key limitations of current antibody-based immunotherapies and offers a promising strategy for sustained cancer immune modulation.
-
Plk1 Phosphorylation Regulates p31comet in Mitotic Checkpoin
2026-07-22
This study elucidates how Polo-like kinase 1 (Plk1) regulates the function of p31comet by phosphorylation at serine 102, controlling the disassembly of mitotic checkpoint complexes (MCC) and thus the fidelity of mitotic progression. The findings clarify a key mechanism that prevents premature checkpoint inactivation during mitosis, with implications for understanding cell division and potential research applications.
-
BMX Kinase–Mediated ATP6V1E1 Phosphorylation Enables Mtb Sur
2026-07-22
The reference study reveals that Mycobacterium tuberculosis (Mtb) manipulates host BMX kinase to phosphorylate the lysosomal V-ATPase subunit ATP6V1E1, thereby suppressing lysosomal acidification and promoting bacterial intracellular survival. These findings uncover a mechanistic axis in host-pathogen interaction, highlighting BMX kinase as a promising target for host-directed tuberculosis therapies.
-
RSV NS3 Hijacks Host Kinase Signaling to Balance Pathogenici
2026-07-21
Zhuang et al. (2025) demonstrate that Rice stripe virus (RSV) NS3 protein exploits host kinase signaling, particularly the OsSnRK3.25-OsCBL1/3-OsRBOHF pathway, to modulate both viral pathogenicity and transmission. This mechanistic insight advances our understanding of virus-vector-plant co-survival strategies and offers translational relevance for research on host signaling manipulation.
-
Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit
2026-07-21
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of high-resolution separation of proteins and peptides in the 1–10 kDa range, where conventional Tris-glycine SDS-PAGE is inadequate. It is intended strictly for research workflows and is not suitable for diagnostic or clinical use.
-
Lipo3K Transfection Reagent: Powering Advanced Gene Expressi
2026-07-20
Lipo3K Transfection Reagent streamlines high-efficiency nucleic acid delivery, even in challenging and sensitive cell lines, with minimal cytotoxicity. Its unique workflow flexibility and nuclear delivery enhancer unlock reliable results for gene expression and RNA interference research, making it a robust choice for cutting-edge experimental designs.
-
Hydroxycinnamic Acids Disrupt COPII-STING Axis to Attenuate
2026-07-20
This study uncovers how hydroxycinnamic acids (HCAs) from traditional medicinal plants directly target the COPII cargo sorting machinery, competitively inhibiting STING trafficking and dampening cGAS-STING-driven inflammation. The findings offer a detailed mechanistic rationale for the metabolic and anti-inflammatory benefits of HCA-rich therapies and open new avenues for targeting autoinflammatory disorders.
-
PD0325901 MEK Inhibitor: Applied Workflows for Cancer Resear
2026-07-19
Harness the power of PD0325901 for precise inhibition of the RAS/RAF/MEK/ERK pathway in oncology and stem cell models. This guide delivers actionable protocols, troubleshooting strategies, and direct translation of pioneering chromatin accessibility research into practical MEK inhibitor assay design.
-
Vincristine Sulfate in Cancer Research: Protocols & Innovati
2026-07-18
Vincristine sulfate is a gold-standard microtubule disrupter with unmatched flexibility for cancer research, enabling precision in both in vitro and in vivo assays. This article details advanced workflows, troubleshooting strategies, and protocol enhancements to maximize its antitumor efficacy—helping researchers overcome common experimental hurdles.
-
Chlorambucil: Strategic Leverage for Translational Oncology
2026-07-17
This thought-leadership article explores the mechanistic and translational significance of chlorambucil, a nitrogen mustard alkylating agent, for cancer researchers. By integrating recent advances in in vitro drug response quantification and workflow optimization, we provide actionable guidance for leveraging APExBIO's high-purity chlorambucil in cutting-edge cytotoxicity assays, with a focus on reproducibility, mechanistic insight, and translational impact.
-
S-Adenosylmethionine (SAM): Methionine Metabolism and Fibros
2026-07-17
Discover how S-adenosylmethionine (SAM) modulates methionine metabolism to influence autophagy and liver fibrosis, with new insights for advanced methylation research. Explore the latest mechanistic findings and practical assay guidance in this in-depth cornerstone analysis.
-
Toremifene in Prostate Cancer: Bridging Hormone and Calcium
2026-07-16
Explore how Toremifene, a selective estrogen-receptor modulator, empowers translational researchers to dissect the interplay between hormone and calcium pathways in prostate cancer. This article integrates mechanistic insights from recent metastasis studies with actionable protocol guidance, competitive benchmarking, and a forward-looking perspective on experimental opportunities.
-
Tioconazole in Antifungal Drug Development: Protocols & Prec
2026-07-16
Tioconazole stands out as an antifungal medication for research, combining potent ergosterol inhibition with high solubility and purity. This article translates advanced studies into stepwise workflows, comparative insights, and troubleshooting strategies for robust antifungal drug development.
-
CCT007093: Precision PPM1D Inhibitor for Dissecting Pyroptos
2026-07-15
CCT007093 is a selective PPM1D inhibitor that enables researchers to interrogate the p38 MAPK signaling pathway in both cancer and acute kidney injury models. Its well-characterized mechanism and quantifiable effects on cellular pyroptosis and cytotoxicity make it a strategic tool for uncovering pathway-specific outcomes and troubleshooting complex bench workflows.
-
Aneugen Molecular Mechanisms: Insights from 27 Reference Che
2026-07-15
The referenced study introduces a tiered molecular assay to distinguish aneugenic mechanisms—tubulin destabilization, stabilization, and mitotic kinase inhibition—across a curated panel of 27 chemicals. By integrating biomarkers and machine learning classification, the assay advances reliable molecular target identification and enhances genomic safety profiling in chemical and drug research.